Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**TexaClear** is a GM Pharmaceuticals over-the-counter consumer-health brand rather than one chemically uniform drug. The brand includes distinct marketed products for allergy and cough symptoms, pain relief, and sleep support, with formulation-specific active ingredients. For example, the fast-acting allergy liquid and tablet products contain chlophedianol hydrochloride and pyrilamine maleate, whereas TexaClear Liquid Pain Reliever contains choline salicylate and caffeine. Consequently, no single active ingredient, mechanism, dosage form, route, or composition can be assigned to the TexaClear brand as a whole.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TexaClear.